KI-Zusammenfassung
Wird ausgewertet
Wird ausgewertet
Wir haben 56 Live-Ergebnisse für basalog insulin glargine geprüft und auf 3 Optionen eingegrenzt, die sich zuerst am meisten zum Vergleichen eignen.
Die Optionen sind Basaglar (Insulin Glargine), Basalog (Insulin Glargine), und Subsidised Insulin Glargine (Lantus) Dispensing.
Quelle: Eli Lilly (Philippines), Inc.
Beschreibung
Basaglar is a long-acting insulin glargine solution available in 100 Units/mL for the effective management of diabetes.
Am besten für
Diabetic patients, Glycemic control und Long Term insulin maintenance
Bewertung
Quelle: Biocon Biologics Philippines Inc.
Beschreibung
Basalog is a long-acting insulin glargine analog designed for consistent diabetes management and is part of affordability initiatives in the Philippines.
Am besten für
Long Acting insulin needs, Diabetes maintenance und Budget Conscious patients
Bewertung
Quelle: Public Healthcare Institutions
Beschreibung
Provision of Lantus (insulin glargine) through public healthcare pharmacies and outpatient clinics. As an SDL-listed drug, it is available to eligible patients at subsidized rates across polyclinics and restructured hospitals.
Am besten für
Subsidized healthcare seekers, Polyclinic patients, Long Term treatment plans und Government Subsidized medication
Bewertung
| Vergleichen | #1Basaglar (Insulin Glargine) | #2Basalog (Insulin Glargine) | #3Subsidised Insulin Glargine (Lantus) Dispensing |
|---|---|---|---|
| Quelle | Eli Lilly (Philippines), Inc. | Biocon Biologics Philippines Inc. | Public Healthcare Institutions |
| Beschreibung | Basaglar is a long-acting insulin glargine solution available in 100 Units/mL for the effective management of diabetes. | Basalog is a long-acting insulin glargine analog designed for consistent diabetes management and is part of affordability initiatives in the Philippines. | Provision of Lantus (insulin glargine) through public healthcare pharmacies and outpatient clinics. As an SDL-listed drug, it is available to eligible patients at subsidized rates across polyclinics and restructured hospitals. |
| Am besten für | Diabetic patients, Glycemic control und Long Term insulin maintenance | Long Acting insulin needs, Diabetes maintenance und Budget Conscious patients | Subsidized healthcare seekers, Polyclinic patients, Long Term treatment plans und Government Subsidized medication |
| Aktion | Basaglar (Insulin Glargine) | Basalog (Insulin Glargine) | Subsidised Insulin Glargine (Lantus) Dispensing |
| Bewertung |
"Basaglar (Insulin Glargine) von Eli Lilly (Philippines), Inc.."
Ich habe dies ausgewählt, weil Basaglar is a reliable long-acting insulin option authorized by the Philippine FDA for consistent glycemic control.
Hinweis: TopFind stellt Vergleichsinformationen nur zu allgemeinen Recherchezwecken bereit.